Key Points
- Investigate the molecular genetic defect causing severe high-density lipoprotein deficiency and premature coronary artery atherosclerosis in an affected kindred.
- Evaluated a homozygous proband with fatal premature atherosclerosis and examined lipid and apolipoprotein profiles across 10 heterozygous family members.
- Conducted restriction fragment length polymorphism analysis using multiple restriction enzymes (BamHI, EcoRI, HindIII, XmnI, PstI, and PvuII) and a 1.1-kb genomic probe 2.5 kb upstream of the apoA-I gene.
- Performed genomic cloning and DNA sequence analysis across the mutated chromosome 11 allele.
- The homozygous proband demonstrated undetectable plasma apoA-I and apoC-III, while 10 heterozygotes exhibited mean apoA-I, apoC-III, apoA-IV, and HDL cholesterol levels at 67%, 57%, 65%, and 62% of normal values, respectively.
- Sequence analysis confirmed the complete deletion of the apoA-I, apoC-III, and apoA-IV gene complex on chromosome 11, with both deletion endpoints mapped within repetitive DNA regions.
Structured PICO
PPopulationA kindred with marked plasma high density lipoprotein (HDL) deficiency and premature atherosclerosis, including 1 homozygous proband and 10 heterozygotes.
CComparatorNormal subjects (implied by comparison of apolipoprotein and HDL levels)
OOutcomeIdentification of the genetic defect causing familial apolipoprotein A-I, C-III, and A-IV deficiencysurrogate
The complete deletion of the apoA-I, -C-III, and -A-IV gene complex on chromosome 11 causes marked HDL deficiency and premature atherosclerosis, supporting an independent role for HDL in the pathogenesis of atherosclerosis.